The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Persistence in muscle of an adenoviral vector that lacks all viral genes
Open accessAbstract
Genetic correction of inherited muscle diseases, such as Duchenne muscular dystrophy, will require long term expression of the recombinant protein following gene transfer. We have shown previously that a new adenoviral vector that lacks all viral genes expressed both full-length dystrophin and β-galactosidase in mdx (dystrophin-deficient) mouse muscle. We observed a significant histologic improvement of vector-transduced mdx muscle before the eventual loss of vector-encoded transgene expression. In this study, we investigated whether an immunological response against vector-encoded β-galactosidase contributed to the loss of vector expression and affected vector persistence in muscle. Intramuscular vector injection in control normal mice resulted in an early and complete loss of β-galactosidase expression accompanied by predominantly CD4 + and CD8 + lymphocytic infiltration and a significant loss of vector DNA. In contrast, intramuscular vector injection in lacZ transgenic mice resulted in persistent expression of β-galactosidase for at least 84 days with no evidence of inflammation or significant loss of vector DNA. Our studies demonstrate that, in the absence of an immune response induced by β-galactosidase expression, an adenoviral vector lacking all viral genes is stably maintained in muscle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
Bett, A. J., Haddara, W., Prevec, L., & Graham, F. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8802 · Cited by 744
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle
Zubrzycka-Gaarn, E. E., Bulman, D. E., Karpati, G., Burghes, A. H. M., Belfall, B., Klamut, H. J., Talbot, J., Hodges, R. S., Ray, P. N., & Worton, R. G. (1988) · Nature · doi:10.1038/333466a0 · Cited by 658
Tripathy, S. K., Black, H. B., Goldwasser, E., & Leiden, J. M. (1996) · Nature Medicine · doi:10.1038/nm0596-545 · Cited by 628
Dai, Y., Schwarz, E. M., Gu, D., Zhang, W. W., Sarvetnick, N., & Verma, I. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1401 · Cited by 591
Kochanek, S., Clemens, P. R., Mitani, K., Chen, H. H., Chan, S., & Caskey, C. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5731 · Cited by 562
Self-citationEfficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice
Ragot, T., Vincent, N., Chafey, P., Vigne, E., Gilgenkrantz, H., Coutont, D., Cartaud, J., Briand, P., Kaplant, J.-C., Perricaude, M., et al. (1993) · Nature · doi:10.1038/361647a0 · Cited by 457
Construction of plasmids that express E.coli β-galactosidase in mammalian cells
MacGregor, G. R., & Caskey, C. T. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.6.2365 · Cited by 452
Gene therapy: adenovirus vectors
Kozarsky, K. F., & Wilson, J. M. (1993) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(93)90126-a · Cited by 419
Development of adenovirus vectors for the expression of heterologous genes.
Berkner, K. L. (1990) · PubMed · Cited by 385
Dai, Y., Roman, M., Naviaux, R. K., & Verma, I. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10892 · Cited by 302
Adenovirus as an expression vector in muscle cells in vivo.
Quantin, B., Perricaudet, L. D., Tajbakhsh, S., & Mandel, J. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2581 · Cited by 296
Recombinant Adenovirus Deleted of All Viral Genes for Gene Therapy of Cystic Fibrosis
FISHER, K. J., CHOI, H., BURDA, J., CHEN, S.-J., & WILSON, J. M. (1996) · Virology · doi:10.1006/viro.1996.0088 · Cited by 291
Kelly, R., Alonso, S., Tajbakhsh, S., Cossu, G., & Buckingham, M. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.2.383 · Cited by 241
Self-citationVincent, N., Ragot, T., Gilgenkrantz, H., Couton, D., Chafey, P., Grégoire, A., Briand, P., Kaplan, J.-C., Kahn, A., & Perricaudet, M. (1993) · Nature Genetics · doi:10.1038/ng1093-130 · Cited by 201
Katz, J., Bodin, E. T., & Coen, D. M. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4288-4295.1990 · Cited by 181
Kumar-Singh, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.7.913 · Cited by 175
Jaynes, J. B., Chamberlain, J. S., Buskin, J. N., Johnson, J. E., & Hauschka, S. D. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.8.2855 · Cited by 172
Harms, J. S., & Splitter, G. A. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.10-1291 · Cited by 161
Vilquin, J.-T., Guérette, B., Kinoshita, I., Roy, B., Goulet, M., Gravel, C., Roy, R., & Tremblay, J. P. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.11-1391 · Cited by 160
Dystrophin Expression in Muscles of mdx Mice After Adenovirus-Mediated In Vivo Gene Transfer
Acsádi, G., Lochmüller, H., Jáni, Á., Huard, J., Massie, B., Prescott, S. M., Simoneau, M., Petrof, B. J., & Karpati, G. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.2-129 · Cited by 149
Deconinck, N., Ragot, T., Maréchal, G., Perricaudet, M., & Gillis, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3570 · Cited by 147
Haecker, S. E., Stedman, H. H., Balice‐Gordon, R. J., Smith, D. B. J., Greelish, J. P., Mitchell, M. A., Wells, A. L., Sweeney, H. L., & Wilson, J. M. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.15-1907 · Cited by 146
Tripathy, S. K., Goldwasser, E., Lu, M. M., Barr, E., & Leiden, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11557 · Cited by 117
Expression of a recombinant dystrophin in mdx mice using adenovirus vector
Alameddine, H. S., Quantin, B., Cartaud, A., Dehaupas, M., Mandel, J., & Fardeau, M. (1994) · Neuromuscular Disorders · doi:10.1016/0960-8966(94)90020-5 · Cited by 25
Recombinant Truncated Dystrophin Minigenes: Construction, Expression, and Adenoviral Delivery
Clemens, P. R., Krause, T. L., Chan, S., Korb, K. E., Graham, F. L., & Caskey, C. T. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.11-1477 · Cited by 25
Self-citation
Cited by
Gene therapy - promises, problems and prospects
Verma, I. M., & Somia, N. (1997) · Nature · doi:10.1038/38410 · Cited by 1,681
Schiedner, G., Morral, N., Parks, R. J., Wu, Y., Koopmans, S. C., Langston, C., Graham, F. L., Beaudet, A. L., & Kochanek, S. (1998) · Nature Genetics · doi:10.1038/ng0298-180 · Cited by 648
Self-citationMorral, N., O’Neal, W., Rice, K., Leland, M., Kaplan, J., Piedra, P. A., Zhou, H., Parks, R. J., Velji, R., Aguilar-Córdova, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12816 · Cited by 409
Self-citationMorsy, M. A., Gu, M., Motzel, S., Zhao, J., Lin, J., Su, Q., Allen, H., Franlin, L., Parks, R. J., Graham, F. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7866 · Cited by 365
Self-citationAdenovirus vectors for gene delivery
Benihoud, K., Yeh, P., & Perricaudet, M. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00007-5 · Cited by 350
Metadata
- Authors
- Chen, H.-H., Mack, L. M., Kelly, R., Ontell, M., Kochanek, S., & Clemens, P. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-03-04
- Volume
- 94
- Issue
- 5
- Pages
- 1645-1650
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2035600956
- Cited by
- 291
- References
- 26
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.